BioMotiv, the for-profit accelerator of The Harrington Project, is the lead funder of Koutif Therapeutics. BioMotiv aims to advance a portfolio of discoveries into new medicines through an innovative, mission-driven model that efficiently aligns capital and collaborations for the benefit of inventors and investors, and ultimately physicians and patients.


We are open to partnering with other organizations. If you or your organization is interested in partnering with Koutif Therapeutics, please contact us via the form below.

Name *